P4‐127: Exploring the Utility of CSF Neurogranin Levels in An Alzheimer's Disease Clinical Trial. (1st July 2016) - Dage, Jeffrey L.; Castelluccio, Peter F.; Anderson, Wesley; Yu, Peng; Talbot, Jayne; Miller, Bradley B.; Herries, Elizabeth M.; Crimmins, Dan; Ladenson, Jack H.; Fagan, Anne M.; Holtzman, David M.; Henley, David B.; et al.